Vivanza Biosciences Ltd 02 Oct 2026 12:00 AM
Vivanza Biosciences receives confirmation certificate from Purva Sharegistry for Q3 2026,
Vivanza Biosciences Limited informed the BSE Limited that it has received a confirmation certificate from Purva Sharegistry (I) Pvt. Ltd., its Registrar and Share Transfer Agent, for the quarter ended September 30, 2026, under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.
Vivanza Biosciences Ltd 28 Sep 2026 12:00 AM
Vivanza Biosciences will halt trading for insiders following Q3 2026 results,
Vivanza Biosciences Limited will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the quarter ending September 30, 2026, in compliance with the Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
Vivanza Biosciences Ltd 12 Aug 2026 12:00 AM
Vivanza Biosciences schedules a board meeting to approve reports and convene its AGM,
Vivanza Biosciences Limited will hold a board meeting on August 17, 2026, at its registered office to approve the Director`s Report and Secretarial Audit Report for the financial year 2025-26, convene the 44th Annual General Meeting (AGM), appoint Mr. Chintan K. Patel as Scrutinizer for the e-voting and poll process, fix September 04, 2026, as the cut-off date for the AGM, and seek approval for the adoption of the Memorandum of Association and Articles of Association, proposed borrowings under Section 180(1)(c) of the Companies Act, 2013, and proposed transactions under Section 185 of the Companies Act, 2013, as applicable, along with proposed investments, loans, guarantees and/or securities under Section 186 of the Companies Act, 2013.
Vivanza Biosciences Ltd 07 Aug 2026 12:00 AM
Vivanza Biosciences consolidated net profit rises 66.67% in the June 2026 quarter,
Net profit of Vivanza Biosciences rose 66.67% to Rs 0.15 crore in the quarter ended June 2026 as against Rs 0.09 crore during the previous quarter ended June 2025. Sales rose 3.91% to Rs 9.29 crore in the quarter ended June 2026 as against Rs 8.94 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales9.298.94 4 OPM %-0.861.68 - PBDT0.190.09 111 PBT0.180.09 100 NP0.150.09 67 Powered by Capital Market - Live News
Vivanza Biosciences Ltd 01 Aug 2026 12:00 AM
Vivanza Biosciences postpones board meeting,
Vivanza Biosciences has postponed the meeting of the Board of Directors which was scheduled to be held on 1 August 2026. The meeting will now be held on 7 August 2026.
Subscribe for our
newsletter
Open Account Now